SecBot SecBot
6-K ·Filed Aug 14, 2026

EVAX

Evaxion A/S
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago SEC0001171843-26-005527
Notable filing: 6-K
Actionable Insight • Neutral

This 6-K is a scheduling notice with no standalone trading signal. The event to watch is the August 20, 2026 Q2 results/business update, for a clinical-stage company with a roughly $27M market cap, the focus will be on cash position, runway, and any pipeline catalysts. Avoid pre-positioning based on this notice alone.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$3.34
T+0 close · Aug 14, 2026 · via day close
Latest settled
−17.66%
T+60 · $2.75
Vs SPY
−14.62%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 14 $3.34entry
  2. T+1 · 3mo ago −6.29%α −5.81% · $3.13
  3. T+5 · 3mo ago −0.90%α +0.47% · $3.31
  4. T+20 · 2mo ago −8.08%α −6.09% · $3.07
  5. T+60 · 8d ago −17.66%α −14.62% · $2.75

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Evaxion A/S filed a Form 6-K on August 14, 2026, announcing that it will release a business update and Q2 2026 financial results on August 20, 2026, before the Nasdaq CM open, followed by a conference call and webcast. This is a routine earnings-date notification with no financial figures or new clinical data disclosed.

Key Facts

  • Evaxion will report Q2 2026 financial results and provide a business update on August 20, 2026, before market open.
  • Executive management will host a conference call and webcast on August 20, 2026 at 14:30 CET / 08:30 EST.
  • Press release dated August 14, 2026 was furnished as Exhibit 99.1 to the 6-K.
  • No financial figures, guidance, or clinical pipeline updates were included in this filing.

Financial Impact

No financial figures disclosed in this filing, the announcement only schedules the Q2 2026 results and business update for August 20, 2026.

Risk Factors

  • No financial data provided, elevated binary event risk at the August 20 earnings release.
  • Clinical-stage TechBio profile implies potential need for additional capital, which may dominate the upcoming update.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-005527
Exhibit: exh_991.htm0001171843-26-005527
Document: 0001171843-26-005527-index-headers.html0001171843-26-005527
Document: 0001171843-26-005527-index.html0001171843-26-005527
Document: 0001171843-26-005527.txt0001171843-26-005527

Track record

50 reports on EVAX

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +22.94% at T+5 after the Mar 5, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  2. Nov 12, 20264d ago Press Release Neutral 1/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  3. Nov 9, 20267d ago 6-K / F-1/A / PRESS-RELEASE Neutral 3/10 Entry $2.75 to $2.86 Now $2.77 +0.73% ▲ +4.00% +4.37% vs SPY
  4. Nov 6, 202610d ago 6-K Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  5. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  6. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  7. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  8. Nov 3, 202613d ago 6-K Neutral 4/10 Entry $2.96 to $2.97 Now $2.77 −6.42% ▲ +0.34% −1.31% vs SPY
  9. Oct 30, 202617d ago 6-K Neutral 2/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
  10. Oct 30, 202617d ago Press Release Neutral 3/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
Showing 10 of 50

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 14, 2026